DAVENPORT FRED B JR

SEC Form 4 insider trading activity

DAVENPORT FRED B JR has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.

On the most recent filing, DAVENPORT FRED B JR is listed as Director at Medpace Holdings, Inc. Inside the rolling window, DAVENPORT FRED B JR reported no open-market purchases and 1 open-market sale totaling $4.4M in MEDP.

Companies traded

Other insiders at MEDP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$4.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MEDPSale$4.4MAug 21SEC ↗
Showing 1–1 of 1
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Oct 30, 2025MEDPSale$3.5M
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has DAVENPORT FRED B JR made?

DAVENPORT FRED B JR has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.

Which companies does DAVENPORT FRED B JR trade?

DAVENPORT FRED B JR has filed SEC Form 4 disclosures for 1 company, including MEDP.

When was DAVENPORT FRED B JR's most recent SEC Form 4 filing?

DAVENPORT FRED B JR's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.

What is DAVENPORT FRED B JR's total buy and sell value in the current window?

Inside the rolling retention window, DAVENPORT FRED B JR bought $0 and sold $4.4M based on SEC Form 4 filings.

What was DAVENPORT FRED B JR's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 7,283 MEDP shares on 2026-08-19, worth $4.4M, per SEC Form 4 filings.